TuisBLISSGVS • NSE
add
Bliss GVS Pharma Ltd
Vorige sluiting
₹163,84
Dagwisseling
₹160,00 - ₹165,99
Jaarwisseling
₹92,15 - ₹172,42
Markkapitalisasie
17,00 mjd INR
Gemiddelde volume
1,55 m
P/V-verhouding
27,15
Dividend-opbrengs
0,31%
Primêre beurs
NSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 2,18 mjd | 2,74% |
Bedryfskoste | 682,58 m | 6,38% |
Netto inkomste | 242,60 m | -42,66% |
Netto winsgrens | 11,14 | -44,22% |
Wins per aandeel | — | — |
EBITDA | 414,11 m | -23,69% |
Effektiewe belastingkoers | 28,04% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 2,20 mjd | 34,93% |
Totale bates | 12,83 mjd | 7,13% |
Totale aanspreeklikheid | 2,34 mjd | 0,06% |
Totale ekwiteit | 10,48 mjd | — |
Uitstaande aandele | 105,02 m | — |
Prys om te bespreek | 1,70 | — |
Opbrengs op bates | — | — |
Opbrengs op kapitaal | 7,68% | — |
Kontantvloei
Netto kontantverandering
| (INR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 242,60 m | -42,66% |
Kontant van bedrywe | — | — |
Kontant van beleggings | — | — |
Kontant van finansiering | — | — |
Netto kontantverandering | — | — |
Beskikbare kontantvloei | — | — |
Meer oor
Bliss GVS Pharma Limited is an Indian pharmaceutical company headquartered in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others.
As of 31 March 2018, its market capitalization is INR 19.20 billion. Wikipedia
Gestig
1984
Webwerf
Werknemers
831
